logo
episode-header-image
May 2024
23m 3s

Dispatch from Omaha: Berkshire after War...

Financial Times
About this episode

Late last year, Warren Buffett’s close business confidant Charlie Munger died at 99. Munger’s death and Buffett’s upcoming 94th birthday have renewed questions about the future of Berkshire Hathaway. What will the empire he’s built look like after he’s no longer at the helm? 


Behind the Money and the FT’s senior corporate finance correspondent Eric Platt travel to Omaha, Nebraska for Berkshire Hathaway’s annual shareholder meeting, to get a better sense of how the next generation will lead America’s “last great” conglomerate. 

 

Clips from CNBC


- - - - - - - - - - - - - - - - - - - - - - - - - - 


For further reading:


Berkshire after Buffett: is Greg Abel up to the top job?

Berkshire after Buffett: prized energy business faces upheaval

Berkshire after Buffett: the risk ‘genius’ pulling the insurance strings

Berkshire after Buffett: can any stockpicker follow the Oracle?


- - - - - - - - - - - - - - - - - - - - - - - - - - 


On X, follow Eric Platt (@ericgplatt) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more.


Read a transcript of this episode on FT.com


Hosted on Acast. See acast.com/privacy for more information.

Up next
Yesterday
Coming soon from Tech Tonic: Defying death
<p>Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing efforts have moved from the super rich to a mass market consumer industry. I ... Show More
1m 30s
Nov 19
What’s the deal with OpenAI's deals?
<p>OpenAI is entering a new era. It's restructured to add a for-profit arm to its business and has signed more than a trillion dollars’ worth of deals to secure chips and build out data centres. But those huge financial commitments also raise massive questions: How will a heavily ... Show More
26m 5s
Nov 12
Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs
Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multibillion-dollar battle for control of biotech start-up Metsera. The FT’s US deals ... Show More
26m 3s
Recommended Episodes
May 2024
Behind the Money: Berkshire after Buffett
<p>This episode features a truncated version of a recent Behind the Money podcast as it travels to Omaha, Nebraska for Berkshire Hathaway’s annual shareholder meeting. At this year’s event, there’s a lingering question over what will happen once Warren Buffett is no longer at the ... Show More
10m 39s
May 2023
Buffett on Apple, Banks, and Value Investing
When Warren Buffett speaks, investors and Wall Street tend to listen. (00:21) Jason Moser discusses: - Berkshire Hathaway's 1st-quarter results and highlights from the annual meeting - Buffett's comments about Apple and the banking industry - Charlie Munger's warning about over- ... Show More
22 m
Jan 2023
Lessons from Buffett’s Investing Framework
Can you think of any stocks in the S&P 500 that will have higher earnings five years from now? Are you 90% confident in your prediction?  If you have a good answer to these questions, then you might be able to start investing like Warren Buffett. Motley Fool Senior Analyst John R ... Show More
25m 28s
Dec 2023
Tribute to Charlie Munger, The Man Who Taught Warren Buffett How to Invest
#475: Born in 1924, Charlie Munger was raised during the Great Depression. At the time of his death on Tuesday, his net worth was estimated at $2.6 billion. But Munger’s greatest achievement wasn’t merely the scorecard of his net worth. His wit and wisdom, which Munger shared wit ... Show More
23m 55s
May 2022
Live From Omaha: Warren Buffett, Charlie Munger, & Bill Murray 5/02/22
<p>Becky Quick highlights the biggest takeaways from the first in-person Berkshire Hathaway Annual Shareholders Meeting since 2019. At what’s affectionately nicknamed the “Woodstock for Capitalists,” Warren Buffett and Charlie Munger answered hours of shareholder questions about ... Show More
33m 56s
Feb 2023
Buffett Brings The Heat
It's not often that the CEO of Berkshire Hathaway gets spicy with his annual letter but he did this time. (0:21) Jason Moser discusses: - Buffett's vigorous defense of share buyback programs - How Berkshire Hathaway's investment portfolio reflects Buffett's beliefs on share buyb ... Show More
28m 58s
Jun 2021
Big Tech In the Capitol Hill Crosshairs -- Cramer Speaks out, Microsoft Joins the $2T Club, Powell Calms the Markets, Southwest's Kelly to Step Down As CEO, Morgan Stanley's Message to Unvaccinated Employees, Buffett Makes a $4.1B Philanthropic Donation and Resigns from the Gates Foundation, plus Bi
Carl Quintanilla, Jim Cramer and David Faber kicked off the show with a closer look at big tech under fire: The House Judiciary Committee set for a markup of antitrust bills which include legislation aimed at breaking up tech giants. Apple among the companies firing back at Congr ... Show More
45m 32s
Sep 2023
TIP573: Berkshire's Beginnings w/ Jacob McDonough
Clay Finck is joined by Jacob McDonough to discuss Berkshire's 1962 beginnings, Warren Buffett's turnaround, and its rise to a $800B valuation by 2023. Jacob McDonough is the author of the book Capital Allocation, which covers the financials of Berkshire Hathaway from 1955 throug ... Show More
1h 16m
Feb 2023
TIP521: Warren Buffett's Shareholder Letters
On today’s episode, Clay reviews Warren Buffett’s shareholder letters and shares his takeaways, and distills some of the biggest lessons he learned. If you asked a lot of value investors, they would tell you that reading Buffett’s letters is equivalent to an MBA on value investin ... Show More
56m 23s